SAN DIEGO and CALGARY, AB, April 10, 2025 /PRNewswire/ -- Oncolytics Biotech® Inc. (NASDAQ: ONCY) (TSX: ONC), a leading clinical-stage company specializing in immunotherapy for oncology, has entered into a share purchase agreement (SPA) with Alumni Capital LP (Alumni), an institutional...
Read More Details
Finally We wish PressBee provided you with enough information of ( Oncolytics Biotech® Funds Pelareorep's Ongoing Clinical Development with a Share Purchase Agreement in Partnership with Alumni Capital )
Also on site :
- Flipster und Aptos Foundation kooperieren, um die Verbreitung von Stablecoin zu fördern und Multichain-Gelegenheiten zu erschließen
- How Development Banks Could Unlock Billions for Renewable Energy
- Flipster et la Fondation Aptos s'associent pour favoriser l'adoption des stablecoins et débloquer des opportunités multichaînes